Brief: Neurosense Says Currently In Advanced Discussions With Several Multi-Billion-Dollar Pharma Cos For Potential Strategic Partnership
28/08/2024 13:13
Aug 28 (Reuters) - Neurosense Therapeutics Ltd NRSN.O :
* NEUROSENSE THERAPEUTICS - CURRENTLY IN ADVANCED
DISCUSSIONS WITH
SEVERAL MULTI-BILLION-DOLLAR PHARMACEUTICAL COS FOR POTENTIAL
STRATEGIC PARTNERSHIP
* NEUROSENSE: POTENTIAL STRATEGIC PARTNERSHIP FOR
DEVELOPMENT,
COMMERCIALIZATION OF DRUG CANDIDATE, PRIMEC, FOR AMYOTROPHIC
LATERAL SCLEROSIS TREATMENT
* NEUROSENSE THERAPEUTICS LTD - ANTICIPATES RECEIVING TERMS
FROM
DISCUSSIONS IN Q4 2024
Source text for Eikon: ID:n0001213900-24-073108
Further company coverage: NRSN.O
((Reuters.Briefs@thomsonreuters.com;))